View in EDS HTML Full Text PDF Full Text

Type 2 inflammation in cystic fibrosis is a predictor of mortality and targeted with CFTR modulator therapy.

Saved in:
Bibliographic Details
Title: Type 2 inflammation in cystic fibrosis is a predictor of mortality and targeted with CFTR modulator therapy.
Authors: Cook DP; Department of Internal Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA., Wu AY; Department of Internal Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA., Thomas CM; Department of Internal Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA., Hamilton RG; Department of Medicine, Division of Allergy and Clinical Immunology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Peebles RS Jr; Department of Internal Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.; Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.; Tennessee Valley Healthcare System, United States Department of Veterans Affairs, Nashville, Tennessee, USA., Kerchberger VE; Department of Internal Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.; Biomedical Informatics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Source: Allergy [Allergy] 2024 Dec; Vol. 79 (12), pp. 3528-3533. Date of Electronic Publication: 2024 Jun 16.
Publication Type: Letter
Journal Info: Publisher: Wiley-Blackwell Country of Publication: Denmark NLM ID: 7804028 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1398-9995 (Electronic) Linking ISSN: 01054538 NLM ISO Abbreviation: Allergy Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38881035
AccessLevel: 2
PubType: Editorial & Opinion
PubTypeId: editorialOpinion
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Type 2 inflammation in cystic fibrosis is a predictor of mortality and targeted with CFTR modulator therapy.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Cook+DP%22">Cook DP</searchLink>; Department of Internal Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.<br /><searchLink fieldCode="AU" term="%22Wu+AY%22">Wu AY</searchLink>; Department of Internal Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Thomas+CM%22">Thomas CM</searchLink>; Department of Internal Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.<br /><searchLink fieldCode="AU" term="%22Hamilton+RG%22">Hamilton RG</searchLink>; Department of Medicine, Division of Allergy and Clinical Immunology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Peebles+RS+Jr%22">Peebles RS Jr</searchLink>; Department of Internal Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.; Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.; Tennessee Valley Healthcare System, United States Department of Veterans Affairs, Nashville, Tennessee, USA.<br /><searchLink fieldCode="AU" term="%22Kerchberger+VE%22">Kerchberger VE</searchLink>; Department of Internal Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.; Biomedical Informatics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%227804028%22">Allergy</searchLink> [Allergy] 2024 Dec; Vol. 79 (12), pp. 3528-3533. <i>Date of Electronic Publication: </i>2024 Jun 16.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Letter
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley-Blackwell%22">Wiley-Blackwell </searchLink><i>Country of Publication: </i>Denmark <i>NLM ID: </i>7804028 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1398-9995 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201054538%22">01054538 </searchLink><i>NLM ISO Abbreviation: </i>Allergy <i>Subsets: </i>MEDLINE; In Process
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38881035
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1111/all.16198
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 3528
    Titles:
      – TitleFull: Type 2 inflammation in cystic fibrosis is a predictor of mortality and targeted with CFTR modulator therapy.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Cook DP
      – PersonEntity:
          Name:
            NameFull: Wu AY
      – PersonEntity:
          Name:
            NameFull: Thomas CM
      – PersonEntity:
          Name:
            NameFull: Hamilton RG
      – PersonEntity:
          Name:
            NameFull: Peebles RS Jr
      – PersonEntity:
          Name:
            NameFull: Kerchberger VE
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 12
              Text: 2024 Dec
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 1398-9995
          Numbering:
            – Type: volume
              Value: 79
            – Type: issue
              Value: 12
          Titles:
            – TitleFull: Allergy
              Type: main
ResultId 1